Revolution Growth’s Latest Investment in Healthcare and AI: Pathos, the Company Re-Engineering the…
Revolution
OCTOBER 31, 2024
How They Do It: The team’s proprietary platform, PathOS™ , gains deep insights into patient responses using a causal AI framework that analyzes gene expression changes related to drug mechanisms and survival outcomes.
Let's personalize your content